亚洲社会药学

本期目录

2022年, 第17卷, 第1期　刊出日期：2022-03-17 上一期   

Select

Evaluation of the Effect of China’s Health Care Reform Based on Prospect Theory Guan Yueyue, Huang Zhe 2022 (1):  1-10.  摘要 ( 358 )   PDF(1626KB) ( 293 )   Objective To evaluate the effect of health care reform policy in China comprehensively and provide suggestions for its further implementation. Methods Data on the effect of health care reform were obtained from “China Health Statistics Yearbook” and National Bureau of Statistics of China and the indicators were selected by corrected item total correlation (CITC) and Cronbach’s α reliability coefficient. Then, the selected indicators were calculated through the prospect theory model. Meanwhile, the gray relation analysis method was introduced to enlarge the differences between the advantages and disadvantages to make the comprehensive evaluation result more obvious. Results and Conclusion The implementation of China’s health care reform has a significant impact on China’s medical and health system. However, the effect of the policy will become less with the increase of the total amount. An effective management can ensure that the policy continues to play its role. 相关文章 | 计量指标

Select

Study on the Matching Degree between Essential Drug List and the Provisions on Drug Coverage in Tertiary Hospitals Wang Chen, Chen Chuhan, Liu Yuhan, Sun Lihua 2022 (1):  11-14.  摘要 ( 330 )   PDF(771KB) ( 221 )   Objective To study the relationship between essential drug list and the provisions on the drug coverage in tertiary hospitals, and put forward the corresponding countermeasures and suggestions for the adjustment of essential drug list and the improvement of relevant policies. Methods Expert consultation and statistical methods were used to classify the drugs in the list of essential drugs according to different diseases. Besides, the matching degree of basic drug allocation and prescription policy was analyzed. Results and Conclusion Among the 685 drugs in the national essential drug list of 2018 edition, 453 drugs were used to treat minor illness, accounting for 66.1% of the total number of essential drug list. 232 drugs were for serious illness or fatal illness, accounting for 33.9% of the total number of essential drug list. The current essential drug list does not match the national requirements for drug plan coverage in tertiary hospitals, which needs further adjustment and improvement. 相关文章 | 计量指标

Select

Strategic Research on Pharmaceutical Enterprises’Participation in National Drug Centralized Procurement Yang Dianzheng, Xu Wenxiu, Qi Yun, Yang Yue 2022 (1):  15-22.  摘要 ( 354 )   PDF(958KB) ( 311 )   Objective To study the influence of national drug centralized procurement policy on pharmaceutical enterprises manufacturing generic drugs and original drugs, so as to provide a reference for them to make different strategic choices. Methods Through the literature research on the related policies and the bidding data, the national drug centralized policies were studied systematically. Combined with the bid-winning price and price reduction range of the winning enterprises in the three rounds of centralized procurement, their difficulties, strategic choices and the winning factors were investigated. Besides, a model was established to clarify the optimal price of enterprises in the process of drug procurement. Results and Conclusion The strategic choices of enterprises in participating national drug centralized procurement are influenced by many factors such as the market share of the original varieties, active pharmaceutical ingredients (APIs) and cost. Therefore, corresponding strategies should be formulated according to the characteristics and interests of enterprises. 相关文章 | 计量指标

Select

Suggestions on Foreign Pharmaceutical Enterprises Dealing with China’s Drug Centralized Procurement – Taking the First Batch of Implementation Results as an Example Li Yunlong, Ning Bowen, Yuan Hongmei 2022 (1):  23-33.  摘要 ( 335 )   PDF(1394KB) ( 608 )   Objective To analyze the impact of the first batch of centralized drug procurement on foreign pharmaceutical enterprises since the national centralized drug procurement policy has brought great impact on pharmaceutical market, and put forward some suggestions on their marketing transformation in China. Methods Firstly, the documents of the drug centralized procurement were studied, and then the sales figures before and after the implementation of the policy were retrieved from MiNET. At the same time, the relevant business adjustment information of foreign pharmaceutical enterprises was collected for analysis. Results and Conclusion The sales of related products of foreign pharmaceutical enterprises have dropped sharply, so they have stripped off these products and reduced their staff. It is suggested that foreign pharmaceutical enterprises should adjust the structure of sales team, strengthen the layout of the market in the county, and accelerate the introduction of innovative drugs to cope with centralized drug procurement. 相关文章 | 计量指标

Select

Analysis and Enlightenment of Pediatric Drug Registration Data in China Su Na , Tian Lijuan 2022 (1):  34-38.  摘要 ( 301 )   PDF(794KB) ( 264 )   Objective To analyze the current status of pediatric drug development in China from the perspective of pediatric drug registration and clinical trials so as to provide a reference for its improvement. Methods The registration and clinical trials explicitly labeled as pediatric drugs were analyzed by using the Insight Database, National Medical Products Administration (NMPA), and other publicly available information. Results and Conclusion The number of applications for pediatric drug registration was 196, and 104 were for domestic drugs, accounting for 53.06%. The number of pediatric drugs included in the priority review was 116, and 70.18% have completed the review. However, the number of new pediatric drug marketing applications is still not optimistic. Only 5 applications for pediatric drug registration are accepted by Center for Drug Evaluation (CDE), accounting for 4.63%. There are difficulties in recruiting pediatric subjects in clinical trials, with 42.08% of completed recruitment projects. Besides, there are few institutions for drug clinical trials, the distribution of institutions and professional certification are uneven. Therefore, enterprises should be encouraged to carry out research and development of pediatric drugs from two aspects: improving the policy for pediatric drugs and strengthening the clinical management of pediatric drugs to guarantee their safe use. 相关文章 | 计量指标

Select

Study on the Application of Quality Risk Management on Drug Collinear Production Xu Wenxiu, Ma Hui, Yang Dianzheng, Wei Jing 2022 (1):  39-49.  摘要 ( 482 )   PDF(1895KB) ( 455 )   Objective To study how to ensure the quality of listed drugs by using quality risk management to control the risks in the drug collinear production because some pharmaceutical companies produce drugs with multiple dosage forms and specifications on the same line to save costs in China. Methods The application status of quality risk management in the production of drugs was analyzed by consulting literature, field investigation and research related policies. Results and Conclusion When introducing co-line products, we should focus on combining product reality, establish a cross-professional team in comprehensive quality, R&D, equipment, and production. Then we can coordinate quality risk management to integrate with each other to avoid “shortcomings” in different links, which will affect the effectiveness of risk management. When a company conducts co-line production, it should rely on quality risk management theories to establish a scientific quality management system, reasonably use quality risk assessment tools to evaluate the types of co-line production, and control key risk factors effectively. These methods can ensure the risk of co-production within an acceptable range. 相关文章 | 计量指标

Select

Design of Pharmaceutical Care Process for Retail Pharmacies Based on Pareto Analysis An Lianyu, Liu Linchuan, Wang Shuling 2022 (1):  50-60.  摘要 ( 364 )   PDF(1555KB) ( 479 )   Objective To study the problems of pharmaceutical care in retail pharmacies and provide reference for the standardized development of pharmaceutical care in China. Methods Based on the literature of CNKI database, Pareto analysis was used to study the present situation of pharmaceutical care in retail pharmacies. Then the following problems in pharmaceutical care were found such as low personnel professional quality, inadequate attention, imperfect laws and regulations, and lack of standard service process. As to the first three problems, there were more research references. But there was less literature on the standard care process. Results and Conclusion Focusing on the customer demand, taking drug sales process as the basic framework of pharmaceutical care standardized process, and combining with the collaboration, the service process including prescription drugs review and OTC drugs purchase consultation is established. This process elaborates the division of staff services as well as the service standards in pre-sale, on-sale, and after-sale stages. Besides, it also puts forward some advice for the previous three problems, which will ensure the smooth implementation of pharmaceutical care in drugstores. 相关文章 | 计量指标

Select

A Review of the Development and Effect of Contraceptive Counseling After Abortion Qiu Yu, Zhang Fang 2022 (1):  61-69.  摘要 ( 419 )   PDF(853KB) ( 343 )   Objective To introduce the background and development of post-abortion services such as contraceptive counseling at home and abroad, and its important role for women so as to provide a reference for the further popularization of this service in China. Methods Chinese and English databases such as CNKI, WanFang Database, VIP, PubMed, and Web of Science were searched to find relevant studies on the implementation of post-abortion service, including post-abortion family planning and post-abortion contraceptive counseling in China. And then the literature on the implementation effect of post-abortion contraceptive counseling and related services was reviewed in China. Results and Conclusion The post-abortion contraceptive counseling service can effectively improve the reproductive health of the patients with induced abortion and the level of knowledge about contraception and birth control, so as to change the contraceptive behavior and adverse psychological state of the patients. Besides. it can guide patients to use more long-term and effective contraceptive measures, thereby reducing the occurrence of unintended pregnancy and repeated abortion. Standardized contraceptive counseling and related services can also improve patient satisfaction. According to the development and implementation effect of post-abortion service and post-abortion contraceptive counseling at home and abroad, it is necessary to further promote post-abortion contraceptive counseling service in the future. Much consideration should be given to carrying out a health technical assessment of the standardized post-abortion contraceptive counseling service as well as its implementation costs. Therefore, medical institutions will have a reference to carry out standardized post-abortion contraceptive counseling service. 相关文章 | 计量指标

Select

Development Status and Enlightenment of Precision Medicine in China Shi Yu, Yang Yu, Hu Rongbo, Xiang You, Tian Lijuan 2022 (1):  70-75.  摘要 ( 339 )   PDF(914KB) ( 284 )   Objective To analyze the development status of precision medicine in China and summarize the problems so as to put forward some countermeasures to promote its high-quality development. Methods Literature research and comparative research were used to study the development status of precision medicine in China from the perspectives of market environment, product research and development (R&D) and policy environment. Results and Conclusion There are some problems in the field of precision medicine in China, such as technical barriers, less investment in new drug R&D, and imperfect regulatory measures. Therefore, some solutions are put forward. First, enterprises should be encouraged to strengthen their cooperation with innovative R&D. Second, the compensation system of drug patent protection period must be established as soon as possible. Lastly, overseas experience should be learned with scientific supervision. 相关文章 | 计量指标

Select

The Development Opportunities and Dilemmas of Telemedicine – Base on the Perspective of Medical Resource Distribution Liu Liang, Wang Shuling, Zhi Yuanyuan, An Lianyu 2022 (1):  76-87.  摘要 ( 409 )   PDF(1715KB) ( 383 )   Objective To discuss issues related to telemedicine in the context of the “Internet plus” and the prevention of novel coronavirus in early 2020, so as to provide some reference for the rapid development of Internet plus telemedicine. Methods Literature analysis method was used to summarize the current status of telemedicine at home and abroad. Descriptive statistical analysis and comparative analysis were also conducted to analyze the data of population and health in the “China Health Statistical Yearbook” and “China Statistical Yearbook” from 2009 to 2018. Results and Conclusion The distribution of medical demand and medical resources is uneven in 31 provinces, municipalities and autonomous regions, such problems are more serious between urban and rural areas in different regions. The population’s demand for medical care and the allocation of medical resources have the characteristics of positive correlation, large urban-rural differences and regional imbalance. Confronted with the situation that the uneven distribution of medical resources provides potential development opportunities for telemedicine and the difficulties in the further development of telemedicine, the government should formulate policies to improve the publicity of telemedicine, setting up a full coverage of telemedicine service system. Besides, hospitals should ensure the information security monitoring. 相关文章 | 计量指标

Select

Research and Suggestions on the Development of Smart Hospital – Taking Hospital A in Liaoning for Example Zhang Yuting, Liu Xiaoxi 2022 (1):  88-93.  摘要 ( 340 )   PDF(789KB) ( 372 )   Objective To study the development of smart hospital to better carry out medical services in the context of the popularization and application of the Internet and the traditional medical model facing the challenge of COVID-19 in 2020. Methods Literature research method was used to analyze the Internet medical mode, and field investigation was made to explore the application of smart medical treatment in hospital A during the pandemic. Results and Conclusion The smart medical platform built by hospital A provides convenient and fast services for patients, but it also exposes the problems in the construction of smart hospitals in China. This paper proposes some suggestions such as hospitals’ participating in the independent review of smart systems and optimizing their information systems. 相关文章 | 计量指标